Ditchcarbon
  • Customers
  1. Organizations
  2. Johnson And Johnson
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 days ago

Johnson And Johnson

Company website

Johnson & Johnson, a leading global healthcare company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1886, the company has established itself as a pioneer in the pharmaceutical, medical devices, and consumer health sectors. With a diverse portfolio that includes renowned products such as Band-Aid, Tylenol, and Neutrogena, Johnson & Johnson is distinguished by its commitment to innovation and quality. The company has achieved significant milestones, including the development of groundbreaking medical technologies and vaccines. As a trusted name in healthcare, Johnson & Johnson holds a strong market position, consistently ranking among the top companies in the industry. Its dedication to improving global health outcomes underscores its reputation as a leader in the healthcare landscape.

DitchCarbon Score

How does Johnson And Johnson's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

81

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

Johnson And Johnson's score of 81 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

90%

Let us know if this data was useful to you

Johnson And Johnson's reported carbon emissions

In 2023, Johnson & Johnson reported total greenhouse gas emissions of approximately 1,892,880,000 kg CO2e, comprising 320,104,000 kg CO2e from Scope 1, 122,776,000 kg CO2e from Scope 2 (market-based), and a significant 1,395,438,000 kg CO2e from Scope 3 emissions. The company has made substantial commitments to reduce its carbon footprint, aiming for a 60% reduction in absolute Scope 1 and 2 emissions by 2030 from a 2016 baseline. This target includes a commitment to achieve near-zero Scope 2 emissions by 2025 and a 30% reduction in Scope 2 emissions from 2020 levels by 2030. Johnson & Johnson has successfully reduced its absolute Scope 1 and 2 emissions by 41% from 2016 to 2022, decreasing from 1,166,456,000 kg CO2e to 683,188,000 kg CO2e. The company also aims to reduce its upstream Scope 3 emissions by 20% over the same target period. These initiatives are part of their broader strategy to achieve net-zero emissions by 2045, demonstrating a strong commitment to sustainability and climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

1990200620072008200920102011201220132014201520162017201820192020202120222023
Scope 1
308,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
751,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
00,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Johnson And Johnson's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Johnson And Johnson is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Johnson And Johnson is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novartis Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Mandom

JP
•
Retail trade services of motor fuel
Updated 17 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Taiho Pharmaceutical Co

JP
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250913.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy